Directory
>
Syed Abutalib
Syed Abutalib
Founder & Editor Advances in Cell & Gene Therapy Wiley Journal | Cancer Treatment Centers of America (acquired by City of Hope)
Illinois, Highland Park, United States
Syed Abutalib
Summary
Syed Abutalib is a distinguished medical professional and the Founder & Editor of the Advances in Cell & Gene Therapy Wiley Journal at the Cancer Treatment Centers of America. With a strong background in hematology and oncology, he has significantly contributed to clinical education and research in the field. Syed holds a Doctor of Medicine degree from the University of Illinois at Chicago, specializing in Hematology & Oncology. His expertise extends to cancer treatment methodologies and educational initiatives aimed at enhancing clinical practice. In addition to his editorial role, he serves as an Assistant Director at the Cancer Treatment Centers of America, where he influences medical education and patient care. Syed's commitment to advancing medical knowledge is further exemplified by his involvement in leukemia research at the University of Chicago. He is passionate about integrating innovative therapies into clinical settings. Syed's leadership and dedication position him as a key figure in the medical community, particularly in cancer treatment and education.
Syed Abutalib
Work Experience
Founder & Editor Advances in Cell & Gene Therapy Wiley Journal at
Cancer Treatment Centers of America (acquired by City of Hope)
May 2020 - Present
Syed Abutalib
Education
University of Chicago, Leukemia Research
University of Illinois at Chicago, Doctor of Medicine (M.D.), Hematology & Oncology -BMT
January 2005 - January 2008
Frequently Asked Questions about Syed Abutalib
What is Syed Abutalib email address?
Syed Abutalib's primary email address is *************@ctca-hope.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Syed Abutalib work for?
Syed Abutalib is a Founder & Editor Advances in Cell & Gene Therapy Wiley Journal at Cancer Treatment Centers of America (acquired by City of Hope).
Where Syed Abutalib graduated from?
Syed Abutalib holds a degree in null from University of Chicago.
How can I directly contact Syed Abutalib?
To contact Syed Abutalib directly, you can use the email address *************@ctca-hope.com. Complete contact information is available upon registration with Muraena.
Who is Syed Abutalib?
Syed Abutalib is a distinguished medical professional and the Founder & Editor of the Advances in Cell & Gene Therapy Wiley Journal at the Cancer Treatment Centers of America. With a strong background in hematology and oncology, he has significantly contributed to clinical education and research in the field. Syed holds a Doctor of Medicine degree from the University of Illinois at Chicago, specializing in Hematology & Oncology. His expertise extends to cancer treatment methodologies and educational initiatives aimed at enhancing clinical practice. In addition to his editorial role, he serves as an Assistant Director at the Cancer Treatment Centers of America, where he influences medical education and patient care. Syed's commitment to advancing medical knowledge is further exemplified by his involvement in leukemia research at the University of Chicago. He is passionate about integrating innovative therapies into clinical settings. Syed's leadership and dedication position him as a key figure in the medical community, particularly in cancer treatment and education.
Syed`s contact details
*************@ctca-hope.com
*************@cancercenter.com
Colleagues
Medical Director, Robert H. Lurie Comprehensive Cancer Center
Research Associate
Medical Director
Management Fellow
Anesthesiologist
CMIO
President and CEO
Medical Director of Case Management
Vice-President, Pharmacy Services
Chief Operating Officer